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7Introduction
Hepatocellular carcinoma (HCC) is the most common form of liver cancer
mi RNA Regulation of gene expression
 Down-regulation of miR-375 has been reported in various tumors
Hyper methylation of CpG islands in miR-375 promoter region down-regulation
of miR-375 in HCC
miR-375 suppresses malignant traits of HCC by targeting AEG-1 and ATG7
 Increasing miR-375 expression decreased HCC cell invasion and proliferation by
targeting oncogene YAP1
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Introduction
miR375 inhibit Akt/Ras induced hepatocarcinogenesis
 Features of gold nanoparticles:
1- biocompatible
2- easy to be surface functionalize
3- suitable for carrying small molecule and macro molecule drugs
4- ability to enter cells
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Nanoparticles for the 
treatment of cancers
Oligonucleotides on their surfaces are resistant to nuclease degradation 
 Very low removal by innate immune response 
 Drug carrier and photothermal therapy
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Nanoparticles for the 
treatment of cancers
 Prepare an AuNP system to deliver miR-375 for miRNA Replacement
therapy in HCC
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Methods 
 Fluorescence imaging
 Transmission electron microscope(TEM)
 Zeta sizer( DLS/ Zeta potential )
 Uv-vis spectroscopy
 Taq-Man qRT- PCR
 Cell counting kit8( CCK-8)
Wound-healing assay
 Colony formation assay
 Immunochimestrary
 Bio luminescence
 TUNEL Assay
 Flow cytometry
Western blot
Matrigel invasion assay
 Synthesis of citrate-coated gold 
nanoparticles ( Frence Method) and 
AuNP-miR-375
 histological examination 
 immunostaining
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Result and methods 
Result and 
methods
Preparation and characterization of AuNPs and AuNP-miR-375
 AuNP were synthesized by using France method (Reduction of golden salt with sodium citrate
salt)
 Two-strand miR-375 mimics Cy3 at the end of the antisense strand
miR-375 linked to AuNPs conalently through a gold- sulfur bond
 A PEG layer on the particle surface was used to stabilize AuNP-miR-375
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Compare the features of AuNP and AuNP-miR-375
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Result and 
methods
Compare the features of AuNP and AuNP-miR-375
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Result and 
methods
 cellular uptake of AuNP-miR-375 and release of miR-375 in
hepatoma cells
 Check cellular uptake of cy3-labeled AuNP-miR-375 by fluorescence microscopy and by flow
cytometry analysis
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Result and 
methods
 cellular uptake of AuNP-miR-375 and release of miR-375 in
hepatoma cells
 Check cellular uptake of cy3-labeled AuNP-miR-375 by flow cytometry analysis
quantify the fraction of cells taking up AuNP-miR-375
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Result and 
methods
 cellular uptake of AuNP-miR-375 and release of miR-375 in
hepatoma cells
 Saturation of cells
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Result and 
methods
 cellular uptake of AuNP-miR-375 and release of miR-375 in
hepatoma cells
 The location of AuNP-miR-375 in the cell
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Result and 
methods
 cellular uptake of AuNP-miR-375 and release of miR-375 in
hepatoma cells
 Use Taq Man qRT-PCR to detect release of mature miR-375 in hepatoma cells
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
 AuNP-miR-375 induce significant cell growth inhibition and cell death in HepG2and Hep3B
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
Measure cell proliferation with various concentration of AuNP-miR-375 (CCK-8)
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
 check the effect of AuNP-miR-375 on motility of HCC
Wound – healing assay
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
check the effect of AuNP-miR-375 on motility of HCC
 Trans well assay
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
check the effect of AuNP-miR-375 on motility of HCC
Matrigel invasion assay
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
 Study of cell proliferation by colony formation assay
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Result and 
methods
AuNP-miR-375 suppresses tumor cell phenotype in vitro
 Study of apoptosis by flow cytometry
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Result and 
methods
AuNP delivered miR-375 can act on its downstream gene targets
 Check expression of miR-375 downstream gene targets in Hep3B cells treated with AuNP-miR-375
(with western blot)
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Result and 
methods
 tissue distribution and toxicity of AuNP-miR-375
 Study of Effective and specific transport of miR-375 to tumor tissue by AuNP-miR-375
 Study of distribution of cy3-labeled miR-375 in tumor bearing BALB/c nude mice following i.v. administration
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Result and 
methods
 tissue distribution and toxicity of AuNP-miR-375
 Evaluate the safety of AuNP-miR-375
 AuNP-miR-375 injection into the mice intravenously through the tail vein
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Result and 
methods
AuNP-miR-375 suppressed tumor growth in primary and xenograft
tumor mouse models
 Study of Anti-tumor effect of AuNP-miR-375 on HepG2 xenograft tumor mouse model
 Inoculation of 5 × 𝟏𝟎𝟔 HepG2 cells in the front armpit of BALB/c nude mice
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Result and 
methods
AuNP-miR-375 suppressed tumor growth in primary and xenograft
tumor mouse models
 Study of therapeutic activity of AuNP- miR – 375 in primary HCC tumor
 Hydrodynamic injection of plasmid carrying two gene ( AKt / Ras) in to mice
34
Result and 
methods
AuNP-miR-375 suppressed tumor growth in primary and xenograft
tumor mouse models
 1- histological examination 2- TUNEL assay 3-immunohistochemical analysis
4- immunostaining
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methods
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Discussion 
 miR-375 important tumor suppressor in HCC
 the lack of an efficient delivery system has been a major obstacle impeding the therapeutic
application of miR-375 in HCC
 In this study AuNP-miR-375 delivery system to deliver miR-375 in to HCC cells and tissues
 AuNP- miR – 375 can enter HCC cells or tissues and function as a tumor suppressor
 AuNP-miR-375 has same biological function as endogenous miR-375
 AuNP-miR-375 restore the regulation networks of miR-375
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Discussion 
 Previous research overexpression of miR-375 in hepatoma cells by transfection of miR-375
precursor with lipofectamine 2000 inhibited tumor growth
 AuNP-miR-375 can overcome physiological obstacles and deliver miR-375 in to HCC tissues in mice
Highly distributed AuNP-miR-375 in HCC tissues
 AuNP can serve as an attractive platform for nucleic acid delivery in cancer treatment
 AuNP are biocompatible and non-toxic
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Discussion 
 AuNP are easy modified to deliver nucleic acid
High uptake efficiency and release of intact miR- 375
 AuNP protect mi RNA from degradation
 AuNP it self possess anti- tumor effect and may improve the efficacy of delivered anti- tumor agents
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40
Conclusion 
 In conclusion, in this study illustrated the reliability of AuNPs to deliver miR-375 into HCC cells and
the therapeutic effects of AuNP-miR-375 in HCC treatment
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conclusion 
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Future perspective 
 Excellent stability and biocompatibility of AuNPs displayed in this study warrant more extensive
investigation of its application in delivery miRNA or siRNA. Our study also highlights the
therapeutic potential of miR-375 in HCC treatment and support the development of more effective
therapeutic strategies that target miR-375 (or other dysregulated miRNAs) by nanotechnology.
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